Daily News & Analysis
  • Home
  • Mumbai
  • India
  • World
  • Money
  • Sport
  • Entertainment
  • Opinion
  • Speak Up
  • Health
  • Lifestyle
  • Sci/Tech
  • Academy
  • Gallery
  • Blogs
  • E-Paper
Saturday, November 21, 2009

Columns

Advanced Search

Pillman
Syndicate
this column

In healthcare, we can at best play catch-up with China

Dan Vasella, the chief executive of Swiss firm Novartis, which has been struggling for the last five years to secure the patent rights in India on Glivec.
November 20, 2009

Case for VCs to tap start-ups in local pharma

With adequate support, some candidates could throw up billion-dollar opportunities.
November 13, 2009

Natco case puts Drug Controller in poor light

For comparison, look at the way the US FDA keeps the record straight.
November 5, 2009

For Big Pharma, there are Geneis galore in India

On their part, small firms with good technologies should improve visibility and relevance.
October 22, 2009

Better monitoring of clinical research an imperative

One instance of wrong trial data can tarnish the industry’s reputation and move investment elsewhere.
October 15, 2009

War of contraceptive pills raises issues of control

Cipla and Mankind Pharma are engaged in a big battle for supremacy in the Indian oral contraceptives market.
October 7, 2009

Rumours of pharma M&As have their own reason

With MNCs keen to tap the local market, there’s no saying who’ll draw blood next.
October 1, 2009

Merck vaccine move signals shift in Big Pharma

MNC has set up firm to develop vaccines for low-income countries. Local firms should take cue
September 25, 2009

Dr Reddy’s: Promoter exit won’t come cheap

Dr Reddy’s officials steadfastly denied any equity dilution by the promoters but that clarification largely failed to quell the theorists.
September 17, 2009

Vaccine delay could put swine flu out of control

Last week, Novartis announced that its pilot trials on 100 volunteers for a vaccine to immunise against swine flu gave strong immune response after one dose.
September 10, 2009

Revamping legal mechanism alone can’t stop spurious drug makers

From the times when offenders found guilty of manufacturing spurious drugs were allowed to go free with a minuscule penalty to now, when a 10-year prison and a hefty charge will be slapped, it is all a move in the right direction.
September 4, 2009

Countering H1N1 will take a concerted attack

Given reports of the virus becoming resistant to both Tamiflu and Relenza, it’s now or never.
August 14, 2009

Roche will only help itself by making drugs affordable

An otherwise media-shy or almost off-media company, Roche India, is suddenly vocal about its efforts to reduce prices of its key life-saving drugs.
August 7, 2009
1
2
3
4
»


Reports
  • Big Pharma must mend its ways to succeed in India
  • Indian pharma faces the big-league challenge
  • Flu: Place public health above corporate interest
  • For local pharma, move to next level will take concerted play
  • Merck’s Schering-Plough buy is a win-win deal

Our columnists
  • Anil Dharker
  • Antara Dev Sen
  • Arati R Jerath
  • Arati R. Jerath
  • Ayaz Memon
  • Cyrus Broacha
  • Dilip Vengsarkar
  • Gaurav Kapur
  • Javed Gaya
  • Madhu Jain
  • Magandeep Singh
  • Malavika Sangghvi
  • Mallika Sarabhai
  • Meghnad Desai
  • N Raghuraman
  • Parsa Venkateshwar Rao Jr
  • R Jagannathan
  • Ranjona Banerji
  • Robin Sharma
  • Sandeep Shanbhag
  • Sathya Saran
  • Siddharth Bhatia
  • Sidharth Bhatia
  • Suresh Nair
  • Venkatesan Vembu
  • Vinay Kamat
Contributors
  • Ankita Pandey
  • Arjun Parthasarathy
  • B Krishnakumar
  • Deblina Chakrabarty
  • Fahad K Samaar
  • Firoz Bakht Ahmed
  • Koel Purie
  • Manjula Pooja Shroff
  • MS Kamath
  • Mukul G Asher
  • Naini Setalvad
  • Prof R Vaidyanathan
  • R N Bhaskar
  • Rakesh Bhatnagar
  • S Gangadharan
  • Shraddha Jahagirdar Saxena
  • Sumit Chakraberty
  • Vijay L Bhambwani
  • Vivek Kaul
  • Yatin Pandya
  • Zaheer Abbas
Popular Columns »
  • Suresh Nair : 2012: The end?
  • R Jagannathan: Fighting Hindi hegemony
  • Anil Dharker : For Muslims, the enemy lies within
  • Ayaz Memon: Twenty years is a couple of lifetimes in any sport
  • Venkatesan Vembu: ‘Superpoor’ India
  • Mallika Sarabhai: Dubai: City of gold
  • Venkatesan Vembu: Before his Asia trip Obama should see 2012
  • Ranjona Banerji : Maharashtra’s issues come home to roost
  • Sandeep Shanbhag : Go for gold — the ETF way
  • Ayaz Memon: Cheats have no place in sport
About us | Contact us | Advertise with us | Subscription | Reprint rights
© 2005-2009 Diligent Media Corporation Ltd. All rights reserved.